Judge Nixes $150M Damages Against Testosterone Drugmaker AbbVie

A U.S. judge on Friday overturned a $150 million verdict against AbbVie Inc. that was the first to result from lawsuits claiming that the company fraudulently misrepresented the risks of its testosterone replacement drug AndroGel. U.S. District Judge Matthew Kennelly …

from News – Insurance Journal